According to Shunqi.com's inquiry, Baekje Shenzhou is a commercial biotechnology company, focusing on the research, development, production and commercialization of innovative drugs. Three products of the company have been approved for marketing and eight products are in the clinical stage. Baekje Shenzhou's product income and cooperation income increased, and the company's total loss in 20021year decreased compared with the same period of last year. Baekje Shenzhou, founded on 20 1 1, is the first biotechnology company listed on NASDAQ, HKEx and Shanghai Stock Exchange. On the whole, Baekje Shenzhou is a biotechnology company with innovative ability and commercial value. It is constantly developing new drugs and has achieved some important results.